Georgetown

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Irritable bowel syndrome1 trial
• Liver cirrhosis1 trial

Phase

• Phase 23 trials

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• GlaxoSmithKline3 trials

Running trials

• Recruiting

  A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

  NCT07519395· Phase 2· GlaxoSmithKline· Source

  Contact: Masi Khaja (principal investigator)

• Recruiting

  A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

  NCT06920043· Phase 2· GlaxoSmithKline· Source

  Contact: Nirupama Jerome (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)1 recruiting
• Irritable bowel syndrome1 recruiting
• Liver cirrhosis1 recruiting

Closed trials

• Completed

  Phase 2b Study of GSK4532990 in Adults With NASH

  NCT05583344· Phase 2· GlaxoSmithKline· Source